QuidelOrtho Corporation Investor Presentation — May 2024

Document content

Financial Results May 8, 20242 © 2024. All Rights Reserved.

Forward -Looking Statements

Forward -Looking Statements: This presentation of QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) contains “forward -looking statements” within the m eaning of the Private

Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly historical , including, but not limited to, QuidelOrtho’s future financial condition and

operating results, and other future plans, objectives, strategies, expectations and intentions. Without limiting the foregoin g, the words “may,” “will,” “would,” “should,” “might,” “expect,” “anticipate,”

“believe,” “estimate,” “plan,” “intend,” “goal,” “project,” “strategy,” “future,” “continue” or similar words, expressions or the negative of such terms or other comparable terminology are intended to

identify forward -looking statements. Such statements are based on the beliefs and expectations of QuidelOrtho’s management as of today and are subject to significant known and unknown risks and

uncertainties. Actual results or outcomes may differ significantly from those set forth or implied in the forward -looking statem ents. The following factors, among others, could cause actual results to

differ from those set forth or implied in the forward -looking statements: supply chain, production, logistics, distribution and labor disruptions and challenges; the challenges and costs of integrating,

restructuring and achieving anticipated synergies as a result of the business combination of Quidel Corporation and Ortho Cli nical Diagnostics Holdings plc; and other macroeconomic, geopolitical,

market, business, competitive and/or regulatory factors affecting the business of QuidelOrtho generally, including those disc ussed in QuidelOrtho’s Annual Report on Form 10 -K for the fiscal year ended